Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

NEUROLOGICAL DISORDERS

Hunting out mutant huntingtin

Huntington disease (HD) is caused by the accumulation of mutant huntingtin (mHTT) that contains an expanded polyglutamine (polyQ) tract. Through screening, Li et al. identified four compounds that tether mHTT, but not wild-type HTT, to the autophagy-related protein LC3. The compounds drove autophagy-dependent reductions of mHTT in neurons from a mouse model of HD. Intraperitoneal delivery of two of the compounds reduced cortical mHTT levels in HD mice and improved behavioural deficits in fly and mouse models of HD. Allele-specific linker compounds might have potential in treating HD and other polyQ disorders.

References

Original article

  1. Li, Z. et al. Allele-selective lowering of mutant HTT protein by HTT–LC3 linker compounds. Nature 575, 203–209 (2019)

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Natasha Bray.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bray, N. Hunting out mutant huntingtin. Nat Rev Neurosci 21, 3 (2020). https://doi.org/10.1038/s41583-019-0248-8

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing